Cheng Hui, Dai Yin-yin, Jiang Ru-hong, Liu Qiang, Sun Ya-xun, Lin Jian-wei, Zhang Zu-wen, Chen Shi-quan, Zhu Jun, Sheng Xia, Jiang Chen-yang
Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310016, China; Department of Cardiology, the First People's Hospital of Xiaoshan, Hangzhou 311200, China.
J Zhejiang Univ Sci B. 2014 Oct;15(10):915-22. doi: 10.1631/jzus.B1400146.
To evaluate the incidence and clinical outcome of adenosine triphosphate (ATP) plus isoproterenol (ISP)-induced non-pulmonary vein (PV) foci before and after circumferential PV isolation (CPVI) during index ablation in patients with paroxysmal atrial fibrillation (PAF).
In 80 consecutive patients undergoing catheter ablation for drug-refractory, symptomatic PAF at our hospital from April 2010 to January 2011, atrial fibrillation (AF) was provoked with ATP (20 mg) and ISP (20 µg/min) administration before and after CPVI. The spontaneous initiation of AF was mapped and recorded.
Before ablation, AF mostly originating from PVs (PV vs. non-PV, 36/70 vs. 3/70; P<0.01) was induced in 39 patients with sinus rhythm. CPVI significantly suppressed AF inducibility; however, more non-PV foci were provoked (post-CPVI vs. pre-CPVI, 13/76 vs. 3/70; P=0.016). Patients with pre- and post-CPVI induced AF (n=49) were divided according to non-PV foci being induced (group N, n=17) or not (group P, n=32). After mean (19.2±8.2) months follow-up, 88.2% (15/17) and 65.6% (21/32) of patients in groups N and P, respectively, were free from AF recurrence (P=0.088).
ATP+ISP administration effectively provokes non-PV foci, especially after CPVI in PAF patients. Although in this study difference did not achieve statistical significance, supplementary ablation targeting non-PV foci might benefit clinical outcome.
评估阵发性心房颤动(PAF)患者在初次消融过程中,环肺静脉隔离(CPVI)前后,三磷酸腺苷(ATP)联合异丙肾上腺素(ISP)诱发非肺静脉(PV)起源灶的发生率及临床结局。
2010年4月至2011年1月,在我院连续80例因药物难治性、有症状的PAF接受导管消融的患者中,在CPVI前后给予ATP(20mg)和ISP(20μg/min)诱发心房颤动(AF)。对AF的自发起始进行标测和记录。
消融前,39例窦性心律患者诱发了AF,其中大部分起源于PV(PV与非PV,36/70 vs. 3/70;P<0.01)。CPVI显著抑制了AF的诱发能力;然而,诱发的非PV起源灶增多(CPVI后与CPVI前,13/76 vs. 3/70;P=0.016)。将CPVI前后诱发AF的患者(n=49)根据是否诱发非PV起源灶分为两组(N组,n=17;P组,n=32)。平均随访(19.2±8.2)个月后,N组和P组分别有88.2%(15/17)和65.6%(21/32)的患者无AF复发(P=0.088)。
ATP+ISP给药能有效诱发非PV起源灶,尤其是PAF患者CPVI后。尽管本研究中差异未达到统计学意义,但针对非PV起源灶的补充消融可能改善临床结局。